N-Oleoyl Alanine
(Synonyms: N-Oleoyl-L-Alanine) 目录号 : GC44440N-Oleoyl Alanine是一种丙氨酸衍生物。
Cas No.:745733-78-2
Sample solution is provided at 25 µL, 10mM.
N-Oleoyl Alanine is aalanine derivatives.
In vivo, During intermittent alcohol consumption in mice, systemic administration of OlGly or N-Oleoyl Alanine (60mg/kg; i.p.) significantly reduced alcohol intake and preference without affecting the hedonic state[1]. N-Oleoyl Alanine (5, 15, 30mg/kg; 2 days; i.p.) attenuates nicotine reward and spontaneous nicotine withdrawal in mice[2].
References:
[1] Shahen-Zoabi S, Smoum R, Bingor A, et al. N-oleoyl glycine and N-oleoyl alanine attenuate alcohol self-administration and preference in mice. Transl Psychiatry. 2023 Jul 31;13(1):273.
[2] Karin KN, Mustafa MA, Poklis JL, et al. N-oleoyl alanine attenuates nicotine reward and spontaneous nicotine withdrawal in mice. Drug Alcohol Depend. 2024 Jun 1;259:111276.
N-Oleoyl Alanine是一种丙氨酸衍生物。
在体内实验中,在小鼠间歇性饮酒期间,系统性给予OlGly或N-Oleoyl Alanine(60mg/kg; 腹腔注射)显著减少了酒精摄入量和偏好,但并未影响享乐状态[1]。N-Oleoyl Alanine(5, 15, 30mg/kg; 2天; 腹腔注射)减轻了小鼠的尼古丁奖赏和自发性尼古丁戒断[2]。
| Animal experiment [1]: | |
Animal models | Female and male ICR mice |
Preparation Method | To test the effects of N-Oleoyl Alanine on nicotine reward, an unbiased conditioned place preference (CPP) model was used. CPP was conducted in a linear series of three interconnected chambers, consisting of two large conditioning chambers that differed in color (black or white) and floor texture (white mesh or black rod) (20 × 20 × 20cm), separated by a smaller gray chamber. On the first day, subjects (n=8/group) were confined to the middle gray chamber for 5min to acclimate before being allowed access to all three chambers for 15min. The time spent in each chamber was recorded to test for potential baseline preferences. Prior to conditioning, there were no systematic biases in baseline preferences for the chambers among the groups. On days 2-4, mice underwent 20-minute conditioning sessions twice daily, 4h apart, conducted by the same investigator. After administration of saline or nicotine, the mice were confined to one of the large chambers. The control group received saline paired with both large chambers, while the nicotine group received nicotine in one large chamber and saline in the other large chamber. The chamber paired with nicotine was randomized for each subject, and treatments were counterbalanced so that half of the mice received nicotine in the morning and saline in the afternoon, while the other half received saline in the morning and nicotine in the afternoon. A maximum dose of 30mg/kg N-Oleoyl Alanine was assessed in CPP, as this dose of N-Oleoyl Alanine was effective in attenuating nicotine-induced CPP. Fifteen minutes before subcutaneous administration of nicotine (0.5mg/kg) or saline, N-Oleoyl Alanine (5, 15, 30mg/kg) or vehicle was administered intraperitoneally (n=8/group), which was 5min before the start of the conditioning session. On the test day (day 5), mice did not receive any injections but were placed in the center chamber with free access to both conditioning chambers during the 20-minute session. A preference score was determined by subtracting the time spent in the drug-paired side during the baseline day from the time spent in the drug-paired side during the test day. |
Dosage form | 5, 15, 30mg/kg; 2 days; i.p. |
Applications | N-Oleoyl Alanine attenuates nicotine reward and spontaneous nicotine withdrawal in mice. |
References: | |
| Cas No. | 745733-78-2 | SDF | |
| 别名 | N-Oleoyl-L-Alanine | ||
| Canonical SMILES | CCCCCCCC/C=C\CCCCCCCC(N[C@@H](C)C(O)=O)=O | ||
| 分子式 | C21H39NO3 | 分子量 | 353.5 |
| 溶解度 | DMF: 10 mg/ml,DMSO: 30 mg/ml,Ethanol: 50 mg/ml,PBS (pH 7.2): 0.25 mg/ml | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.8289 mL | 14.1443 mL | 28.2885 mL |
| 5 mM | 565.8 μL | 2.8289 mL | 5.6577 mL |
| 10 mM | 282.9 μL | 1.4144 mL | 2.8289 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















